Last reviewed · How we verify
Infex 200 IR
Infex 200 IR is an antibiotic that works by inhibiting bacterial cell wall synthesis.
Infex 200 IR is an antibiotic that works by inhibiting bacterial cell wall synthesis. Used for Community-acquired pneumonia, Nosocomial pneumonia.
At a glance
| Generic name | Infex 200 IR |
|---|---|
| Sponsor | Neutec Ar-Ge San ve Tic A.Ş |
| Drug class | carbapenem antibiotic |
| Target | penicillin-binding proteins (PBPs) |
| Modality | Small molecule |
| Therapeutic area | Infectious diseases |
| Phase | Phase 3 |
Mechanism of action
It achieves this by binding to the penicillin-binding proteins (PBPs) located inside the bacterial cell wall, thereby inhibiting the cross-linking of peptidoglycan and ultimately leading to cell lysis and death.
Approved indications
- Community-acquired pneumonia
- Nosocomial pneumonia
Common side effects
- Nausea
- Diarrhea
- Vomiting
- Abdominal pain
- Headache
Key clinical trials
- Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |